Our presence in Boston is growing across our two sites based in the Seaport area of Boston: Lilly Seaport Innovation Center (LSC) and Lilly Harborside Research & Development Labs (LHL). These research and development facilities are dedicated to advancing Lilly's efforts in RNA and DNA-based therapies as well as discovering new drug targets to create life-changing medicines across several disease states, including diabetes, obesity, cardiovascular diseases, neurodegeneration, chronic pain, immunology and hearing health.
In addition to Research & Development, LSC also houses the east coast location of Lilly's shared innovation accelerator, Lilly Gateway Labs, which provides participating companies with state-of-the-art lab space and unique access to Lilly scientists, researchers and executives, as well as exposure to Lilly's functional and scientific expertise.